CLINICAL_TRIALS
trial_result
· 2022-09-21
Clinical Trial Update: Reducing Hemarthrosis in Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid [Phase 4]
Summary
Phase 4 clinical trial evaluating intravenous tranexamic acid to reduce knee bleeding after tibial tubercle osteotomy; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Tibial Tubercle Osteotomy | Phase 4 | Status: COMPLETED | Results posted: 2022-09-21